Keywords: dynavax, flu, vaccine, deal, novartis, firm, technologies

Dynavax in flu vaccine deal with Novartis

Article | 04 August 2008

Print This

US firm Dynavax Technologies has announced an agreement with Novartis Vaccines and Diagnostics, a US unit of the Swiss drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in